Lawsuit Overview
September 3, 2013 (Shareholders Foundation) - An investor who currently holds shares of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) filed a lawsuit in effort to halt the proposed takeover of Onyx Pharmaceuticals, Inc. by Amgen for $125 per NASDAQ:ONXX share. The plaintiff alleges that the defendants breached their fiduciary duties by ageing to sell Onyx Pharmaceuticals too cheaply to ...
You must register (for free) or login to view the entire case.